Speaker Profile
Ph.D., Assistant Professor (Adjunct), U. of Minnesota
Biography
Scott Grosse is a health economist who researches the population health and economic impacts of newborn screening and genetic testing initiatives. He has published roughly 300 journal articles, including policy analyses, evidence reviews, and commentaries. He worked at the CDC for more than 28 years before retiring in December 2024. He was also part of an Evidence-based Review Group that was contracted to conduct evidence syntheses for conditions nominated for the US Recommended Uniform Screening Panel. He also collaborated for many years with CDC’s Office of Genomics and Precision Public Health on assessments of the clinical and diagnostic utility of testing for hereditary disorders in adults. He is a member of the American Economic Association, International Health Economics Association, ISPOR, the International Society for Neonatal Screening, and the International Consortium on Newborn Sequencing.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Wendy Chung, Boston Children's / Harvard
PMWC Award Ceremony
• Wendy Chung, Boston Children's / Harvard (Pioneer)
• Eric Lander, Broad Institute (Pioneer)
Featured Speakers
• Wendy Chung, Boston Children's / Harvard
• Eric Lander, Broad Institute
• Zhanzhi (Mike) Hu, Project GUARDIAN / Columbia
• Tippi MacKenzie, UCSF
• Ryan Taft, Genetic Alliance
• Heidi Cope, RTI International
• Michele Caggana, NY State DOH Wadsworth Center
• Elad Ziv, UCSF
• Scott Grosse, University of Minnesota
• Mike Talkowski, Mass General / Harvard
• F. Sessions Cole, WashU
• Lee Hood, Phenome Health / ISB
• Trey Ideker, UC San Diego
• Ralph Snyderman, Duke
• Craig Mundie, Mundie & Associates
• George Church, Harvard
Beyond the Exome: Solving Undiagnosed Disease
The next layer of rare-disease diagnosis beyond standard sequencing.
Population Genomic Screening
From newborn sequencing to implementation, evidence, economics, and equity.
Structural Variants & Long Reads
Solving cases missed by conventional sequencing.
Launching the Human Phenome Initiative
From genome to phenome as a global health infrastructure challenge.
Data-Driven Health
AI, longitudinal data, and personalized clinical medicine.
Engineering the Future of Health
Genomes, cells, and engineering biology as precision medicine moves upstream.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
